Dr. Jessica Rose at the FDA Open Public Hearing

Dr. Jessica Rose at the FDA Open Public Hearing

“There’s an over 1000% increase in the total number of adverse events just for 2021 and we are not done with 2021 … In my opinion [the risks] outweigh any potential benefits…with these products, especially in children.”

Image is of FDA Building 51 houses the Center for Drug Evaluation and Research